Total OXPHOS Human WB Antibody Cocktail (ab110411)
Key features and details
- Assay type: Quantitative
Overview
-
Product name
Total OXPHOS Human WB Antibody Cocktail -
Assay type
Quantitative -
Species reactivity
Reacts with: Human -
Product overview
ab110411 contains 5 mAbs, one each against Complex I subunit NDUFB8 (ab110242), Complex II subunit 30kDa (ab14714), Complex III subunit Core 2 (ab14745), Complex IV subunit II (ab110258), and ATP synthase subunit alpha (ab14748) as an optimized premixed cocktail. The cocktail is suitable for Western Blotting analysis of the relative levels of the 5 OXPHOS complexes in mitochondrial preparations from human sources.
Altered levels of assembly can arise from mutations in individual subunits, mutations in assembly factors for the complex(es), mtDNA depletion or as a result of physiological and or pathological changes e.g. hormone treatment, exercise, diet or oxidative stress.
The mAbs in the cocktail were chosen because they are against a subunit that is labile when its complex is not assembled. Moreover, the combination is readily resolved in SDS-PAGE when the appropriate gel conditions are used (Please refer to application notes).
The Western blot cocktail is supplied at a concentration of 1.5 mg/mL.
The five antibodies provided in the cocktail are all mouse monoclonal antibodies.
We recommend using a high pH CAPS buffer / PVDF transfer protocol when using this antibody for Western blot. Please contact us for more details.
Due to a policy change, the previously provided control for this kit has been removed.
We do not recommend to boiling samples since it will cause signal reduction of several bands. We recommend warming to 37°C for 30 minutes prior to loading.
-
Notes
Related products
Review the mitochondrial assay guide, or the full metabolism assay guide to learn about more assays for metabolites, metabolic enzymes, mitochondrial function, and oxidative stress, and also how to assay metabolic function in live cells using your plate reader.
-
Tested applications
Suitable for: WBmore details
Properties
-
Storage instructions
Store at +4°C. Please refer to protocols. -
Components 360 µg Premix Cocktail of 5 monoclonal antibodies 1 x 360µg -
Research areas
-
Alternative names
- OXPHOS cocktail
Associated products
-
Corresponding Antibody
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab110411 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB |
Use at an assay dependent concentration.
Recommended starting dilutions is 1:200 - 1:1000. However, optimal diltuion should be established by the end-user. We recommend using a high pH CAPS / PVDF transfer protocol when using this antibody for Western blot. Please contact us for more details. We do not recommend to boiling samples since it will cause signal reduction of several bands. We recommend warming to 37°C for 30 minutes prior to loading. |
Notes |
---|
WB
Use at an assay dependent concentration. Recommended starting dilutions is 1:200 - 1:1000. However, optimal diltuion should be established by the end-user. We recommend using a high pH CAPS / PVDF transfer protocol when using this antibody for Western blot. Please contact us for more details. We do not recommend to boiling samples since it will cause signal reduction of several bands. We recommend warming to 37°C for 30 minutes prior to loading. |
Images
-
Gel: Non-reduced Denaturing (4-12%)
Lanes 1-3: contain 3 individual Human B cell lymphoma samples 50 μg loaded per lane.
Blocked for 1 hour with 5% Milk at room temperature.
ab110411 used as per instructions.
Secondary: HRP-conjugated anti-mouse IgG uesd at 1/300
Detection method: ECL+ 2 minutes exposure.
-
Each lane contains 10 µg of mitochondria isolated from MRC5 fibroblasts.
ab110411(MS601) was used to label lane 6, and the individual antibodies
comprising the cocktail were used for lanes 1-5.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (431)
ab110411 has been referenced in 431 publications.
- van Beek SMM et al. Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trial. Nat Commun 14:173 (2023). PubMed: 36635304
- Hao X et al. Disrupted mitochondrial homeostasis coupled with mitotic arrest generates antineoplastic oxidative stress. Oncogene 41:427-443 (2022). PubMed: 34773075
- Mennuni M et al. Metabolic resistance to the inhibition of mitochondrial transcription revealed by CRISPR-Cas9 screen. EMBO Rep 23:e53054 (2022). PubMed: 34779571
- Minnock D et al. Altered muscle mitochondrial, inflammatory and trophic markers, and reduced exercise training adaptations in type 1 diabetes. J Physiol 600:1405-1418 (2022). PubMed: 34995365
- Van Bergen NJ et al. Biallelic Variants in PYROXD2 Cause a Severe Infantile Metabolic Disorder Affecting Mitochondrial Function. Int J Mol Sci 23:N/A (2022). PubMed: 35055180